Eli Lilly and Company has emerged as in the manufacturing of tirzepatide, a groundbreaking drug for type 2 diabetes. Tirzepatide, a dual GIP and GLP-1 receptor agonist, showcases significant capacity to improve glycemic control and reduce cardiovascular risks. The complex manufacturing process of tirzepatide requires a series of carefully contro… Read More